Moderna seeks FDA clearance for fourth COVID-19 scan

(Washington, DC) – Drugmaker Moderna on Thursday asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The request is broader than rival drug company Pfizer’s request earlier this week for the regulator to approve a boost for all seniors.

In a press release, the company said the approval request for all adults was introduced to “give some flexibility” for the Centers for Disease Control and Prevention and health providers to defines the “appropriate use” of the second booster dose of the mRNA vaccine, “Including those at increased risk for COVID-19 due to age or comorbidities.”

US officials have been laying the groundwork to provide additional booster dose to enhance vaccine protection against severe illness and death from COVID-19. The White House has sounded the alarm that it needs Congress “urgently” to approve additional federal government funding to secure additional doses of the COVID-19 vaccine, or for booster shots or follow-up immunizations. variant.

US health officials now recommend a primary series of two doses of Moderna vaccine and a booster dose several months later.

Moderna says its request for an additional dose is based on “recently published data generated in the United States and Israel following the emergence of Omicron. ”

On Tuesday, Pfizer and partner BioNTech asked U.S. regulators to authorize a booster dose of their COVID-19 vaccine for the elderly, said data from Israel showing older adults will benefit.

Other must-read stories from TIME

Contact us in

Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button